NAS181 free base is a potent and selective antagonist of the rat 5-HT1B receptor (Ki = 47 nM), exhibiting 13-fold selectivity over the bovine 5-HT1B receptor (Ki = 630 nM); it increases serotonin turnover and synaptic 5-HT concentration by inhibiting terminal r5-HT1B autoreceptors.